This week brought major developments related to medication abortion access and federal reproductive health policy. For now, the Supreme Court has temporarily preserved nationwide access to mifepristone through telehealth prescribing and mail distribution by extending its administrative stay in Louisiana v. FDA through May 14 while the Court considers whether lower court restrictions should remain in effect. At the same… (Eisen, May 12, 2026) #Health Equity, #Women’s Health